Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

Autor: Carlos Guijarro, Farid Zand, Mohamed solyman Kabil, Sven Trelle, Birgitte Tholin, Belén Comeche, Johan Alexander Azañero Haro, Gonzalo Sierra Torres, Quarraisha Abdool Karim, Kari Tikkinen, Jean-michel Molina, Atousa Hakamifard, George M Varghese, Oscar Josue Ponce Ponte, Mazin Barry, Pilar Vizcarra, Niccolo Riccardi, Natalia Pérez-Macias, Aynaa AlSharidi, Nelson Lee, Alexandra Binnie, Firouzé BANI-SADR, Beatriz Díaz-Pollán, Aldo Pietro Maggioni, Ilkka Kalliala, Florian Desgranges, Anders Benjamin Kildal, Katerina Nezvalova-Henriksen, Corinne Merle, Andrés Martín Alcántara, Benjamin Gaborit, Daniel Lozano Martín, Antonio Ramos-Martinez, Miguel Villegas-Chiroque, Fredy Orlando Guevara Pulido, Ana Fernández-Cruz, Cormac McCarthy, Thesla Palanee-Phillips, Annalisa Marinosci, Abdullah Assiri, Florent Wallet, Juan Pablo Balbuena, Avik Ray, Francesc Puchades, Rajarao Mesipogu, Marjatta Sinisalo, Jonathan Sterne, Antonio Portolés, Heike Cappel-Porter, Jussi Mustonen, Jeremy Nel, BRUNO MOURVILLIER, María Consuelo Miranda Montoya, Chiara Fanciulli, L Marjukka Myllärniemi, Edinson Dante Meregildo Rodriguez, Alexy Inciarte, Mohamed Hassany, François Danion, Elena Muñez Rubio, Jean-Pierre QUENOT, Esperanza Merino de Lucas, Sheela Godbole, Luis Guillermo Barreto Rocchetti, Katerina Spasovska, William Connors, Kiana Shirani, Umang Agrawal, Srinivas Murthy, Bjorn Blomberg, Vasee Moorthy, Amith Balachandran, Antonio De Pablo Esteban, Mahnaz Amini, Dag Arne Lihaug Hoff, Zeinab Siami, Guillaume Martin-Blondel, Heng Gee Lee, Thrilok Chander Bingi, Vijay Krishnan, ANA BELEN RIVAS PATERNA, Eric D'Ortenzio, Samy Zaky, Carlos Arturo Alvarez-Moreno, Alonso Soto, VIKAS MARWAH, Marco Tulio Medina, Zaira R. Palacios-Baena, Jean-Sébastien Hulot, Miguel Angel Hueda Zavaleta, Felipe García, Francisco Fanjul

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (6), pp.497-511. ⟨10.1056/NEJMoa2023184⟩
Pan, Hongchao; Peto, Richard; Henao-Restrepo, Ana-Maria; Preziosi, Marie-Pierre; Sathiyamoorthy, Vasee; Abdool Karim, Quarraisha; Alejandria, Marissa M; Hernández García, César; Kieny, Marie-Paule; Malekzadeh, Reza; Murthy, Srinivas; Reddy, K Srinath; Roses Periago, Mirta; Abi Hanna, Pierre; Ader, Florence; Al-Bader, Abdullah M; Alhasawi, Almonther; Allum, Emma; Alotaibi, Athari; Alvarez-Moreno, Carlos A; ... (2021). Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. New England journal of medicine NEJM, 384(6), pp. 497-511. Massachusetts Medical Society MMS 10.1056/NEJMoa2023184
The New England journal of medicine, Vol. 384, no.6, p. 497-511 (2021)
2020, ' Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2023184

The authors report interim results of the WHO Solidarity trial of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with Covid-19. Effects on overall mortality, initiation o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16340988d9937ca8ef93ad35262d9e60
https://hdl.handle.net/20.500.12866/9103

How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians

Autor: Niccolò Riccardi, Sara Occhineri, Elisa Vanino, Roberta Maria Antonello, Agostina Pontarelli, Francesca Saluzzo, Tiziana Masini, Giorgio Besozzi, Marina Tadolini, Luigi Codecasa, on behalf of StopTB Italia

Publikováno v: Antibiotics, Vol 12, Iss 12, p 1733 (2023)

Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to a

Externí odkaz: https://doaj.org/article/61777a83b2c74354b0ac4317dd3f660e

Migrants and imported disease: Trends of admission in an Italian infectious disease ward during the migration crisis of 2015–2017

Autor: Filippo Del Puente, Niccolò Riccardi, Lucia Taramasso, Giovanni Sarteschi, Rachele Pincino, Antonio Di Biagio

Publikováno v: BMC Public Health, Vol 20, Iss 1, Pp 1-5 (2020)

Abstract Background Since 2014, the migrant population residing in Europe has dramatically increased. Migrants’ unmet health needs represent a barrier to integration and should be promptly addressed, without stigma, in order to favour resettlement.

Externí odkaz: https://doaj.org/article/eba77eeae0f9417cac8b01e6ab836ef3

Pretomanid for tuberculosis treatment: an update for clinical purposes

Autor: Sara Occhineri, Tommaso Matucci, Laura Rindi, Giusy Tiseo, Marco Falcone, Niccolò Riccardi, Giorgio Besozzi

Publikováno v: Current Research in Pharmacology and Drug Discovery, Vol 3, Iss , Pp 100128- (2022)

Coronavirus disease (COVID-19) pandemic determined a 10 years-set back in tuberculosis (TB) control programs. Recent advances in available therapies may help recover the time lost. While Linezolid (LZD) and Bedaquiline (BDQ), previously Group D secon

Externí odkaz: https://doaj.org/article/e733c91c0ab14f13bf3b84e094fb5ff6

Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

Autor: Francesca Tamarozzi, Veronica A Fittipaldo, Hans Martin Orth, Joachim Richter, Dora Buonfrate, Niccolò Riccardi, Federico G Gobbi

Publikováno v: PLoS Neglected Tropical Diseases, Vol 15, Iss 3, p e0009191 (2021)

BackgroundHepatosplenic schistosomiasis (HSS) is a disease caused by chronic infection with Schistosma spp. parasites residing in the mesenteric plexus; portal hypertension causing gastrointestinal bleeding is the most dangerous complication of this

Externí odkaz: https://doaj.org/article/c20546ce5cb5411abc8014ec80477a5d